Biotech: Pressemitteilungen - Kategorie - Seite 21

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Microbix Reports Fiscal 2016 Results Continued Profitability and Strong Revenue Growth

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/23/16 -- Microbix Biosystems Inc. (TSX: MBX) ("Microbix" or the "Company"), an innovator of biological products and technologies, today re ...

Sernova to Present Corporate and JDRF-Sponsored Clinical Trial Update at the Biotech Showcase(TM) 2017 Healthcare Conference in San Francisco

LONDON, ONTARIO: LONDON, ONTARIO -- (Marketwired) -- 12/22/16 -- Sernova Corp. (TSX VENTURE: SVA)(OTCQB: SEOVF)(FRANKFURT: PSH), a clinical stage regenerative medicine company, is pleased to announce that Dr. Philip ...

Prima BioMed Receives UK Approval for AIPAC Study

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/19/16 --Competent Authority and Ethics Committee approval received in the United Kingdom for AIPACRecruitment of patients in second cohort of AIPAC study compl ...

Powerful Marketing Platform and Strong Clinical Trials Results Boost Revenues for Innovus, Says CEO Bassam Damaj

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 12/19/16 -- , an independent investment publication that highlights important technologies and companies, today released an interview with , CEO of , Inc. (OTCQB: IN ...

Prima BioMed Announces ADR Ratio Change

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/18/16 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima", the "Company") announces a ratio change for the Company's American Depo ...

Flamel Technologies Doses First Patient in REST-ON Phase III Trial of FT218 for Excessive Daytime Sleepiness & Cataplexy

LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 12/16/16 -- Flamel Technologies SA (NASDAQ: FLML) today announced that the first patient has been dosed in its Rest-On Phase III clinical trial of FT218, a once-night ...

IBEX Reports First Quarter Fiscal 2017 Results

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 12/16/16 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the quarter ended Oc ...

Philippe P. Calais to Join Marina Biotech's Board of Directors

CITY OF INDUSTRY, CA: CITY OF INDUSTRY, CA -- (Marketwired) -- 12/14/16 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for ca ...

Helix BioPharma Corp. Announces Fiscal First Quarter 2017 Results

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 12/13/16 -- Helix BioPharma Corp. (TSX: HBP)(FRANKFURT: HBP), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, t ...

2017 Biotech Predictions Foretell Race Towards Cloud, e-Commerce and Greater Transparency

PALO ALTO, CA: Bioz Anticipates Industry to "Catch Up" in Adopting Trending Technologies to Accelerate Life Science Research in Year Ahead ...

Microbix Arranges New Revolving Credit Facility

TORONTO, ONTARIO: Concurrently Renegotiates Terms of Convertible Debentures ...

Arch Biopartners Appoints Patrick Vink to Board of Directors

TORONTO, CANADA: TORONTO, CANADA -- (Marketwired) -- 12/12/16 -- Arch Biopartners, Inc., (TSX VENTURE: ACH) (OTCBB: FOIFF) (Arch or the Company) is pleased to announce that Dr. Patrick Vink has joined its Board of D ...

Corcept Therapeutics Announces Encouraging Results of Phase 1/2 Trial of Mifepristone Plus Eribulin in Triple-Negative Breast Cancer

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 12/10/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre ...

Avid Bioservices to Participate at Upcoming Life Sciences Industry Conferences

TUSTIN, CA: TUSTIN, CA -- (Marketwired) -- 12/09/16 -- Avid Bioservices, Inc., a wholly owned subsidiary of Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) (NASDAQ: PPHMP), today announced that the company will a ...

Sermonix Pharmaceuticals Signs Exclusive Licensing Agreement to Further Explore Lasofoxifene for Breast Cancer Treatment

COLUMBUS, OH: Women's oncology pharmaceutical company also raises more than $2 million in preferred seed funding round ...

VBI Vaccines Closes $23.6 Million Financing from Perceptive Advisors

CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 12/06/16 -- VBI Vaccines Inc. (NASDAQ: VBIV) (TSX: VBV) ("VBI"), a clinical-stage biopharmaceutical company developing infectious disease and ...

Atossa Genetics to Present at the 9th Annual LD Micro Main Event Conference on December 7, 2016

SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 12/01/16 -- (NASDAQ: ATOS) announced today that Kyle Guse, CFO and General Counsel, will be a featured presenter at the 9th annual LD Micro Main Event Conference on D ...

Trillium Therapeutics Announces Conference Call and Webcast on December 5th to Discuss TTI-621 Data Presented at ASH

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 11/29/16 -- Trillium Therapeutics Inc. (TSX: TR)(NASDAQ: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of canc ...

Sermonix Pharmaceuticals to Present Poster on Physician Perceptions of Menopausal SERMs at San Antonio Breast Cancer Symposium

COLUMBUS, OH: COLUMBUS, OH -- (Marketwired) -- 11/28/16 -- Sermonix Pharmaceuticals LLC, a specialty pharmaceutical company focused on the development and commercialization of female-specific oncology products, to ...

ANGLE plc: Issue of Share Options

GUILDFORD, SURREY: GUILDFORD, SURREY -- (Marketwired) -- 11/28/16 -- ANGLE plc (AIM: AGL) (OTCQX: ANPCY)AIM: AGL; OTCQX: ANPCY("ANGLE" or the "Company")ANGLE plc (AIM: AGL; OTCQX: ANPCY), the specia ...


Seite 21 von 255:  « ..  20 21 22  23  24  25  26  27  28  29  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z